In conclusion, we have demonstrated that Lp-PLA2 is significantly associated with decreased NAFLD risk in a large Chinese population, and increased Lp-PLA2 levels may be useful as an independent protector against NAFLD. The gene discussed is PLA2G7; the disease is metabolic dysfunction-associated steatotic liver disease.